60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Signed Clinical Trial Agreements With Three Planned Trial Sites for the Tafenoquine Babesiosis Study
藥品公司60 Degrees藥品股份上漲,該公司已與三個計劃進行試驗的試驗場所簽訂了對於惡性瘧原蟲病的託磷脲試驗協議。
60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Signed Clinical Trial Agreements With Three Planned Trial Sites for the Tafenoquine Babesiosis Study
藥品公司60 Degrees藥品股份上漲,該公司已與三個計劃進行試驗的試驗場所簽訂了對於惡性瘧原蟲病的託磷脲試驗協議。
使用瀏覽器的分享功能,分享給你的好友吧